CHROMQ provides NABL-traceable calibration support and reference standards that help laboratories maintain testing accuracy and audit readiness
Gaurav Shroff, Director
India’s pharmaceutical industry is entering a new era defined not just by manufacturing scale, but by precision, compliance, and research-driven innovation. As global regulators tighten standards around quality testing, data integrity, and laboratory validation, pharmaceutical companies are investing heavily in modern laboratory infrastructure capable of meeting international benchmarks.
According to the India Brand Equity Foundation (IBEF), the Indian pharmaceutical industry is expected to reach USD 130 billion by 2030, supported by growing exports, R&D investments, and rising demand for high-quality manufacturing systems.
This evolution has significantly increased the importance of advanced laboratory equipment, analytical instruments, compliant consumables, and technical support ecosystems that ensure accuracy and reliability throughout the production cycle. Pharmaceutical laboratories today are expected to operate with higher levels of automation, traceability, and regulatory readiness than ever before.
Amid this transformation, ChromQ Instruments has emerged as a specialised player focused on bridging the gap between global laboratory technologies and the practical requirements of Indian pharmaceutical and life sciences companies. The company has positioned itself not merely as an equipment distributor, but as a technical and compliance-driven solutions partner helping laboratories transition toward globally aligned quality environments.
Building CHROMQ with Scientific Expertise
CHROMQ was founded during the Covid period by professionals with strong academic and industry exposure in the life sciences sector. The founder’s educational journey through IIT Roorkee, followed by postgraduate studies in Belgium and France, provided firsthand experience with advanced laboratory systems and global quality practices.
While working closely with laboratory technologies, the founding team identified a major gap in the Indian market. Many suppliers were operating purely as transactional distributors, supplying instruments without offering technical understanding, scientific consultation, or application-level support. Laboratories often struggled to bridge the gap between sophisticated imported technologies and their real-world implementation requirements.
This challenge became the foundation for CHROMQ’s business model. The company was built around the idea of creating a consultative distribution platform where scientific expertise and technical ownership are central to every client engagement. Instead of simply supplying instruments, the firm focuses on helping laboratories adopt technologies that align with compliance goals, operational efficiency, and long-term performance.
Today, the company specialises in authorised pharmaceutical laboratory instruments and consumables designed for highly regulated laboratory environments.
CHROMQ provides NABL-traceable calibration support and reference standards that help laboratories maintain testing accuracy and audit readinessGaurav Shroff, Director
Supporting a Compliance-Driven Industry
India’s pharmaceutical ecosystem is rapidly shifting from volume-led manufacturing to value-led manufacturing. With increasing scrutiny from global regulatory authorities such as the USFDA and WHO-GMP, pharmaceutical companies are under pressure to strengthen laboratory systems, improve documentation practices, and maintain complete data integrity.
CHROMQ sees this shift as a defining opportunity for the industry. The company actively supports laboratories moving toward paperless quality systems and automated testing environments designed to meet evolving regulatory standards, including 21 CFR Part 11 compliance requirements.
As pharmaceutical manufacturing expands into biologics, injectables, and complex formulations, laboratories require more sophisticated analytical infrastructure capable of delivering precision, repeatability, and traceability. CHROMQ positions itself at the centre of this transition by connecting Indian laboratories with globally recognised technologies while ensuring local technical support and service responsiveness.
This combination of global capability and local execution has helped the company strengthen its relevance in an increasingly compliance-focused market.
Reliability and Regulatory Focus
Operating in a pharmaceutical laboratory infrastructure requires a deep commitment to reliability and regulatory accountability. CHROMQ follows a rigorous vendor evaluation framework before onboarding any manufacturer or product into its portfolio.
The company evaluates not only product performance but also the manufacturer’s quality management systems, service capabilities, spare parts availability, and long-term support readiness within India. Reliability, according to the company, is non-negotiable in pharmaceutical environments where even minor equipment inconsistencies can affect quality outcomes and regulatory compliance.
CHROMQ also operates with strong internal governance and traceability systems aligned with pharmaceutical industry expectations. Every piece of equipment and consumable is tracked through serial numbers or batch codes, enabling full transparency across the supply chain. This level of traceability becomes especially important during regulatory inspections and quality audits, where documentation integrity is critical.
The company’s emphasis on process discipline reflects its understanding that pharmaceutical laboratories today require not just suppliers, but dependable infrastructure partners capable of supporting long-term compliance goals.
Beyond Equipment Supply
For CHROMQ, the relationship with clients does not end with equipment delivery. The company has built its service model around long-term laboratory support through calibration services, technical consultation, application assistance, and annual maintenance programmes.
The firm provides NABL-traceable calibration support and reference standards that help laboratories maintain testing accuracy and audit readiness. The company also conducts technical workshops and user support sessions aimed at helping laboratory teams fully utilize instrument capabilities and minimise operational downtime.
At a time when global supply chains remain vulnerable to geopolitical instability and currency fluctuations, CHROMQ has also focused on strengthening inventory reliability. By maintaining stock of critical consumables and fast-moving instruments through its warehouse operations in Indore, the company aims to reduce delays and ensure continuity for pharmaceutical clients operating under strict production timelines.
Looking ahead, CHROMQ’s long-term vision is closely aligned with India’s rise as a global pharmaceutical and research hub. As the country expands its role in biologics, injectables, and advanced pharmaceutical manufacturing, the demand for world-class laboratory infrastructure will continue to grow.
Through its blend of technical expertise, compliance understanding, and service-driven execution, it is steadily positioning itself as a trusted contributor to the future of pharmaceutical quality and laboratory excellence in India.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")